StemCyte Inc., a wholly owned subsidiary of StemCyte International Ltd., announced today that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for its ...

The Center for Multiple Sclerosis and Autoimmune Neurology at Mayo Clinic is advancing the use of stem cell therapy for neurological conditions.

Singapore, Singapore, November 22nd, 2024, ChainwireKipley.ai, an AI deployment solutions provider under the KIP Group, has ...

The Global Institute of Stem Cell Therapy and Research (GIOSTAR), based here which is focused on developing innovative ...

These therapies offer the potential for both personalized* and universal* applications. In personalized therapies ... In ...

Harvard Medical School will accredit a new Continuing Education course on stem cell therapies developed by the International ...

Growing wood directly from stem cells could offer an alternative to cutting threatened hardwood trees, but it isn't clear if ...

Research on stem cells is ongoing, but they're approved to treat a certain group of diseases. Here's what doctors say about ...

The companies have teamed up to develop Takeda’s proprietary induced pluripotent stem cell (iPSC) derived CAR-T cell ...

Omeros Corporation (Nasdaq: OMER) today announced an update on its progress toward planned resubmission of its biologics license application (“BLA”) for narsoplimab, the company’s first-in-class ...

An ambitious project launched in 2016 has made a dent in one of biology’s greatest challenges — with more than 3,600 ...

The current negative list restricts foreign investment in the development and application of human stem cells and gene ...